SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001842612-23-000007
Filing Date
2023-06-13
Accepted
2023-06-13 21:09:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 153203
2 ACKNOWLEDGMENT dorvalpoa1.pdf EX-24 110853
  Complete submission text file 0001842612-23-000007.txt   307575
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Subject) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35703 | Film No.: 231012803
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INSULET CORPORATION 600 TECHNOLOGY PARK DRIVE, SUITE 200 BILLERICA MA 01821
Business Address
Dorval Allison (Reporting) CIK: 0001625110 (see all company filings)

Type: 144